Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

Short-term acute careNonprofit (private)Major teachingMcLaren Health Care Corporation

Karmanos Cancer Center

4100 John R, Detroit, MI, 48201 · (800) 576-6266

$401.6M

Net patient revenue, FY 2025

Beds

115

FY 2025

Star rating

3 of 5

Patient survey: 4 of 5

Net patient revenue

$401.6M

FY 2025

Net income

$55.3M

Patient care margin -30.3%

Discharges

2,351

Occupancy 55.6%

Clinicians

331

Medicare clinicians who work here

Finances and location

Yearly cost reports (fiscal years as the hospital reports them) and where the hospital is

Revenue and expenses by fiscal year

Net patient revenueOperating expenses

12 hospitals in the system. Zoom, drag, or use the buttons.

Loading map...
This hospital11 other hospitals of the systemDashed pins are approximate (center of the ZIP code): 1.

Financials by fiscal year

US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.

Fiscal yearNet patient revenueOperating expensesPatient care marginNet incomeDischargesUncompensated careMedicare daysMedicaid days
2025$401.6M$523.1M-30.3%$55.3M2,351$2.2M17.5%1.2%
2024$396.5M$480.4M-21.2%$64.6M2,240$1.8M21.3%0.6%
2023$335.6M$419.2M-24.9%$39.7M2,176$2.8M20.6%1.1%
2022$284.8M$363.8M-27.8%$24.3M2,183$3.0M21.2%4.3%
2021$271.9M$337.0M-23.9%$20.4M2,694$1.8M20.8%3.0%
2020$222.2M$290.3M-30.6%$20.5M2,660$1.8M25.7%3.3%

Quality of care

Official hospital quality measures with the national median across hospitals. For ratios, 1.00 means as many cases as expected.

Death rates

Hospital-wide death rate within 30 days3.4%US median 3.9%
Death rate for pneumonia patients16.3%US median 15.2%

Readmissions

Readmission rate for pneumonia16.8%US median 17.2%

Patient safety

Serious complications (patient safety composite)1.01US median 0.96

Infections

C. diff intestinal infections (ratio to expected)0.98US median 0.28
Central line bloodstream infections (ratio to expected)0.78US median 0.48
MRSA bloodstream infections (ratio to expected)1.33US median 0.60
Catheter urinary tract infections (ratio to expected)0.00US median 0.40

Patient survey

Doctors always communicated well80%US median 79%
Nurses always communicated well85%US median 80%
Patient survey summary star rating4 of 5US median 3 of 5
Area around the room always quiet at night64%US median 59%
Patients who rated the hospital 9 or 10 out of 1078%US median 72%
Room and bathroom always clean68%US median 73%
Patients who would definitely recommend the hospital78%US median 71%

Timely and effective care

Patients prescribed 2 or more opioids or opioids with benzodiazepines at discharge13%US median 15%
Patients who got appropriate care for severe sepsis and septic shock33%US median 65%
Healthcare workers given the flu vaccine75%US median 79%

Hospital profile

Medicare certification number (CCN)
230297
Organization NPI
1316900277
Legal name
Barbara Ann Karmanos Cancer Hospital
County
Wayne County, MI
Ownership
Nonprofit (private)
Teaching
Major teaching
In Medicare since
2005
Full-time employees
976

Clinicians who work here

Medicare clinicians who list this hospital, by specialty

Specialties

Find doctors and clinicians

Other McLaren Health Care Corporation hospitals

All 12
HospitalPlace
McLaren FlintFlint, MI
McLaren MacombMount Clemens, MI
McLaren Bay RegionBay City, MI
McLaren Greater LansingLansing, MI
McLaren Northern MichiganPetoskey, MI
McLaren Port HuronPort Huron, MI

Other hospitals in Detroit

All Michigan hospitals

Similar short-term acute care hospitals in Michigan

Closest in number of beds

Medicare hospital stays

Inpatient stays by diagnosis related group (DRG), 2024

Diagnosis groupStaysAverage chargeMedicare pays per stayAll hospitals
DRG 871 SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MCC31$67,050.87$18,152.71$15,524.21
DRG 016 AUTOLOGOUS BONE MARROW TRANSPLANT WITH CC/MCC23$121,711.43$49,472.35$55,916.46
DRG 014 ALLOGENEIC BONE MARROW TRANSPLANT17$526,137.41$156,006.53$125,266.48
DRG 837 CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY A15$87,865.47$40,094.07$50,344.29
DRG 847 CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC13$34,630.92$10,225.08$12,158.78
DRG 164 MAJOR CHEST PROCEDURES WITH CC11$53,013.45$20,078.55$20,435.81

Medicare outpatient services

Hospital outpatient services by payment group (APC), 2024

Service groupServicesPatientsMedicare pays per serviceAll hospitals
APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage219205$1,123.45$1,219.56
APC 5372 Level 2 Urology and Related Services15456$469.18$502.15
APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage10985$1,957.34$2,141.49
APC 5183 Level 3 Vascular Procedures10699$2,236.72$2,405.01
APC 5182 Level 2 Vascular Procedures5347$1,082.93$1,204.32
APC 8011 Comprehensive Observation Services5137$1,920.76$2,090.36
APC 5374 Level 4 Urology and Related Services3225$2,446.31$2,629.24
APC 5373 Level 3 Urology and Related Services3226$1,429.27$1,516.28
APC 5165 Level 5 ENT Procedures2726$4,109.39$4,436.36
APC 5362 Level 2 Laparoscopy and Related Services2626$7,429.78$8,164.45
APC 5302 Level 2 Upper GI Procedures2412$1,332.16$1,444.50
APC 5154 Level 4 Airway Endoscopy2422$2,627.83$2,832.62

Payments from drug and device companies

Payments drug and device companies reported to this hospital

CompanyPaymentsAmount
Genmab U.S., Inc.GMAB logoGMAB329$2.0M
Regeneron Pharmaceuticals, Inc.REGN logoREGN408$1.7M
AstraZeneca UK LimitedAZN logoAZN2$1.1M
Merck Sharp & Dohme LLCMRK logoMRK28$1.1M
Janssen Research & Development, LLCJNJ logoJNJ219$816K
Pfizer Inc.PFE logoPFE153$642K
Celgene CorporationBMY logoBMY7$526K
AstraZeneca Pharmaceuticals LPAZN logoAZN8$363K
Genentech, Inc.ROG.SW logoROG.SW95$325K
Bayer Healthcare Pharmaceuticals Inc.BAYN.DE logoBAYN.DE146$318K

Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.

Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.

How to cite: DataPorium, “Karmanos Cancer Center”, https://dataporium.tech/healthcare/hospitals/230297-karmanos-cancer-center-detroit

Karmanos Cancer Center in Numbers

Karmanos Cancer Center: Beds, Owner, Finances and Quality

Karmanos Cancer Center is a nonprofit short-term acute care hospital in Detroit, MI with 115 beds, part of McLaren Health Care Corporation. Net patient revenue grew 41% from fiscal year 2022 to 2025, to $401.6 million. It is a major teaching hospital. It is one of 12 hospitals of McLaren Health Care Corporation, based in Grand Blanc, MI.

What stands out

  • Its margin on patient care (net patient revenue minus operating expenses) was -30.3% in fiscal year 2025, against a median of 0.9% for the 15 Michigan short-term acute care hospitals closest to it in size.
  • It does not list emergency services; 79 of the 90 short-term acute care hospitals in Michigan do.

Frequently asked questions

How does Karmanos Cancer Center compare with other hospitals in Michigan?

With 115 beds, Karmanos Cancer Center is the 51st largest of the 90 short-term acute care hospitals in Michigan. Among the 15 Michigan short-term acute care hospitals closest to it in size (88 to 154 beds), the median patient care margin is 0.9% (Karmanos Cancer Center: -30.3%) and the median star rating is 2.5 of 5 (Karmanos Cancer Center: 3). Its net patient revenue rose 1.3% from fiscal year 2024 to 2025, to $401.6M.

How many beds does Karmanos Cancer Center have?

Karmanos Cancer Center in Detroit, MI has 115 beds (fiscal year 2025 cost report); 123 beds are certified for Medicare. It discharged 2,351 inpatients that year, with 55.6% of its beds in use on average.

Is Karmanos Cancer Center profitable?

In fiscal year 2025 (ending 2025-09-30), Karmanos Cancer Center reported net patient revenue of $401.6M and operating expenses of $523.1M, a margin on patient care of -30.3%. After other income and expenses its net income was $55.3M (9.6% of revenue), so it made a profit that year.

What health system owns Karmanos Cancer Center?

Karmanos Cancer Center is part of McLaren Health Care Corporation, a health system with 12 hospitals based in Grand Blanc, MI. It is a nonprofit hospital.

What is Karmanos Cancer Center's star rating?

Karmanos Cancer Center has an overall rating of 3 out of 5 stars in the official hospital quality ratings. Patients rate it 4 out of 5 stars in the patient survey.

Does Karmanos Cancer Center have an emergency room?

No, Karmanos Cancer Center does not list emergency services.

How many doctors work at Karmanos Cancer Center?

331 Medicare clinicians list Karmanos Cancer Center as a hospital they work at, most often in Internal Medicine, Certified Registered Nurse Anesthetist (Crna), Nurse Practitioner.

What are the most common Medicare hospital stays at Karmanos Cancer Center?

In 2024, Karmanos Cancer Center had 110 Medicare inpatient stays in 6 diagnosis groups. The most common was DRG 871 (septicemia or severe sepsis without mv >96 hours with mcc) with 31 stays; Medicare paid $18,152.71 per stay on average, compared with $15,524.21 across all hospitals.

How much did drug and device companies pay Karmanos Cancer Center?

In 2025, drug and device companies reported $11.7M in payments to Karmanos Cancer Center ($168K general and $11.5M for research) from 44 companies.

LinkedInLinkedInXXYouTubeYouTube